• 2020.1019

    On September 4, 2020, the British Medical Journal (BMJ) online published an article entitled: A living WHO guideline on drugs for covid-19. This guideline reflects an innovative collaboration between the WHO and the MAGIC Evidence Ecosystem Foundation, driven by an urgent need for global collaboration to provide trustworthy and living covid-19 guidance. A standing international panel of content experts, patients, clinicians, and methodologists, free from relevant conflicts of interest, produce recommendations for clinical practice. The panel follows standards, methods, processes, and platforms for trustworthy guideline development using the GRADE approach. 

  • 2020.1019

    Cochrane, JBI, Campbell Collaboration and Guidelines International Network announced the host of the Global Evidence Summit (GES) 2021 is the Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (CEBHCKT).

  • 2020.0305

    The conference theme will address the important issue of Making Health Choices Transparent, Equitable and Efficient. The conference will explore this across a range of important perspectives, including strengthening global guideline quality, technology, collaboration and adaptation.The conference is being hosted by McMaster University, and will be held at the Westin Harbour Castle Hotel and Conven

  • 2019.0217

    ‍‍The conference theme isTrustworthy Evidence For Questions That Matter - The value of guidelines in 21st century healthcare,and will be relevant to all health care professionals and anyone with an interest in addressing evidence-practice gaps by promoting best practice and improving the quality and safety of health care. And this isthe first Guidelines-International-Network (G-I-N) conference i

Register MORE
  • 2020.1012
    At present, the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) dominate the publication of international guidelines of ankylosing spondylitis (AS). These guidelines provide authoritative recommendations for medical staffs around the world and are updated every 2-3 years. In China, the guidelines for diagnosis and treatment of rheumatic diseases are mainly formulated by Chinese Rheumatology Association of Chinese Medical Association. Combined with the characteristics of Chinese patients,the guidelines published by ACR and EULAR was revised by the Chinese Rheumatology Association so as to make the guidelines more in line with the actual situati -on in China. However, the Association had not updated the guideline since the Chinese Journal of Rheumatology published a guideline for the diagnosis and treatment of ankylosing spondylitis in 2010. Moreover, there was no guideline for the diagnosis and treatment of ankylosing spondylitis with integrated traditional Chinese and Western Medicine at home and abroad in recent 10 years, which has become a major obstacle to the standardized diagnosis and treatment of ankylosing spondylitis in China. Finally, Rheumatology is too young for other subjects, and the level of doctors from the grass-roots unit are uneven. Most of them rely personal experiences more than on guidelines to diagnose and treat AS, which lead to many misdiagnosis and the unsatisfied curative effects . It is urgent for us to formulate a guideline to standardize their clinical diagnosis and treatment of AS. To sum up, based on the latest research evidence and the clinical practice in China, we will formulate a guideline in accordance with the authoritative guidelines for developing guidelines,.
  • 2020.1011

Cumulative Users: 644

Cumulative Registered Guidelines: 142